Update on Novel B-Cell Receptor Signaling Inhi... - CLL Support

CLL Support

22,512 members38,664 posts

Update on Novel B-Cell Receptor Signaling Inhibitors from NCCN 8th Annual Congress on Hematologic Malignancies

AussieNeil profile image
AussieNeilAdministrator
1 Reply

The article below from OncLive, provides a high level overview of trials experience of the new drugs Ibrutinib, Idelalisib and IPI-145 by Jeffrey Jones, MD, from The Ohio State University to the NCCN 8th Annual Congress on Hematologic Malignancies. Brief mention is also made of the benefits observed when using Ibrutinib with Ofatumumab (Arzerra) and rituximab.

Drugs targeting B-cell receptor (BCR) signaling pathways are improving outcomes for patients with B-cell lymphomas, including chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma (NHL), and mantle cell lymphoma (MCL). These novel agents include PI3-Kinase (PI3K) inhibitors (eg, idelalisib) and Bruton’s tyrosine kinase (BTK) inhibitors (eg, ibrutinib), and are considered a breakthrough for CLL and other B-cell lymphomas.

At the recent NCCN 8th Annual Congress on Hematologic Malignancies, Jeffrey Jones, MD, from The Ohio State University Comprehensive Cancer Center and James Cancer Hospital and Solove Research Institute, updated listeners on these two new targeted drug classes:

onclive.com/publications/ob...

Neil

(This Musk Lorikeet proved challenging to photograph, as it was very actively foraging for nectar and pollen from the bottlebrush shrub.)

Written by
AussieNeil profile image
AussieNeil
Administrator
To view profiles and participate in discussions please or .
Read more about...
1 Reply
MartyR profile image
MartyR

Neil, it seems to be the conference time of the year - yet another positive article about these inhibitors

Although is it compulsory to swallow a dictionary before standing on stage!

Definition of concomitant in English --- naturally accompanying or associated:

she loved travel, with all its concomitant worries

Great photo - most UK birds are black, grey or brown - I suppose our birds needed to hide from hunters whereas your birds can see and hear a boomerang coming!!!!

Marty

You may also like...

Update on my status 3 month post chemo (FCR)- doing well - no malignant B cells in my MRD test

all normal, neutrophils are going up, red blood cells and platelets going up since last visit 3...

Ibrutinib Slow but steady foreward movement.

tyrosine kinase (BTK) inhibitors. Data suggest ibrutinib covalently bonds to BTK in malignant B...

A Conversation with Dr Tam about Zanubrutinib: A Novel BTK Inhibitor

2–inducible T-cell kinase (ITK), Janus kinase 3 (JAK3), human epidermal growth factor receptor 2...

ASH 2019: A Clinical Trial of Cannabis As Targeted Therapy for Indolent Leukemic Lymphoma

Sativex to elderly patients with indolent B-cell lymphoma with regards to adverse events. We show...

Second-Generation BTK Inhibitors Hit the Treatment Bullseye With Fewer Off-Target Effects

involve sustained distal B-cell receptor signaling through PIK3-AKT (protein kinase B) pathway...